Robert W. Baird Upgrades Waters (NYSE:WAT) to Outperform
Robert W. Baird upgraded shares of Waters (NYSE:WAT – Free Report) from a neutral rating to an outperform rating in a research report sent to investors on Wednesday, Marketbeat Ratings reports. The brokerage currently has $407.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $396.00. WAT has been […]
Robert W. Baird upgraded shares of Waters (NYSE:WAT – Free Report) from a neutral rating to an outperform rating in a research report sent to investors on Wednesday, Marketbeat Ratings reports. The brokerage currently has $407.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $396.00. WAT has been […]
